Meta-analyses of these and other studies have demonstrated: Reductions in total cholesterol typically in the range of 15% from baseline, varying by agent and population Decreases in LDL cholesterol ranging from 17%, generally more modest than dedicated lipid-lowering therapies Reductions in triglycerides of 515%, with greater effects often seen in those with higher baseline levels Variable effects on HDL cholesterol , with small increases (1-2%) or neutral effects reported The magnitude of lipid improvements appears to correlate with the degree of weight loss achieved, suggesting that metabolic benefits may be partially mediated through adiposity reduction
This means, 22 mg/kg per week for a person of 80 kg, while we administered 15 mg/kg twice a week
pmid:14970312 13
Non-animal Methods in Science and Regulation
"This information includes how they are manufactured, whether they are sterile, how they work in the body, what side effects they may cause and what substances these products actually contain." The regulator said examples of unapproved peptide products included those containing BPC157, GHKCu, TB500, retatrutide and CJC1295, often supplied in injectable form
Istifadah N